Detalles de la búsqueda
1.
Hepatocyte growth factor-regulated tyrosine kinase substrate (Hgs) is involved in BMP signaling through phosphorylation of SMADS and TAK1 in early mouse embryo.
Dev Dyn
; 240(11): 2474-81, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21953618
2.
Bmpr1a is required for proper migration of the AVE through regulation of Dkk1 expression in the pre-streak mouse embryo.
Dev Biol
; 341(1): 246-54, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20211162
3.
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.
Breast Cancer Res Treat
; 119(1): 127-36, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19690954
4.
Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.
Cancer Sci
; 99(1): 145-51, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17970786
5.
[Hemodialysis patients].
Nihon Rinsho
; 70 Suppl 7: 697-700, 2012 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-23350488
6.
Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
J Clin Oncol
; 23(10): 2172-84, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15800310
7.
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
J Clin Oncol
; 21(6): 991-8, 2003 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12637462
8.
[Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].
Gan To Kagaku Ryoho
; 32(13): 2071-7, 2005 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-16352931
9.
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.
Int J Oncol
; 20(3): 517-25, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11836563
10.
Impact of established risk factors for breast cancer in nulligravid Japanese women.
Breast Cancer
; 10(1): 45-53, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525763
11.
Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
Breast Cancer
; 9(4): 323-8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12459714
12.
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.
Breast Cancer
; 11(2): 194-202, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15550867
13.
Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women.
Breast Cancer
; 10(1): 63-9, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525765
14.
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Breast Cancer
; 10(4): 307-11, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14634508
15.
[Phase I single-dose administration study of exemestane in postmenopausal women].
Gan To Kagaku Ryoho
; 29(7): 1179-87, 2002 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-12145999
16.
[Phase I multiple-dose administration study of exemestane in postmenopausal women].
Gan To Kagaku Ryoho
; 29(7): 1189-97, 2002 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-12146000
17.
[A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Gan To Kagaku Ryoho
; 31(4): 539-47, 2004 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-15114697
18.
[Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents].
Gan To Kagaku Ryoho
; 29(7): 1211-21, 2002 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-12146002
19.
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer].
Gan To Kagaku Ryoho
; 29(7): 1199-209, 2002 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-12146001
20.
[Axillary lymph node dissection in clinically node-positive breast cancer].
Nihon Geka Gakkai Zasshi
; 103(11): 831-4, 2002 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-12478861